Search Results 301-310 of 1555 for 域名跳转,外贸公司网络推广方式,地推游戏推广,阿里外贸网站,安全磁力搜索引擎等欢迎访问六五Ai站群搜尋引擎系統V.25.05.20官方网站:www.65.hk

1. Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · Overview · Participation eligibility.

2. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

   Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...

3. Zenith® p-Branch® OTS Multicenter Study - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

   The purpose of this study is to test any good and bad effects of adding the drug Blinatumomab to different doses of standard combination of chemotherapy drugs.

5. A Study To Investigate The Safety And Tolerability Of Ziftomenib In Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, Or 7+3+Quizartinib In Patients With AML - Mayo Clinic

   Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML) with certain genetic alterations. This ...

6. A Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Unilateral Head and Neck Cancer - Mayo Clinic

   About this study. Compared to IMRT, PBRT is thought to give less radiation exposure to the surrounding healthy tissues. It is possible that side effect ...

7. PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. Nidhi Jalan Sakrikar, Ph.D. - Training and Education - Center for Clinical and Translational Science (CCaTS)

   Read the profile of Nidhi Jalan Sakrikar, Ph.D., a KL2 scholar through the Mayo Clinic Center for Clinical and Translational Science (CCaTS).

9. A Study of the Safety of Treatment with Iluvien® by Assessing Intraocular Pressure Signals in Patients with Diabetic Macular Edema - Mayo Clinic

   The purpose of this study is to evaluate the safety of using iluvien to treat patients with diabetic macular edema, by assessing intraocular pressure.

10. Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - Mayo Clinic

    The purpose of this study is to assess the efficacy of paltusotine vs placebo in reducing flushing episodes. Participation eligibility. Participant eligibility ...